We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




COVID-19 Infection Fatality Ratio is Close to One Percent

By HospiMedica International staff writers
Posted on 10 Nov 2020
A new report reveals that the COVID-19 infection fatality ratio (IFR) is 1.15% in high-income countries, but substantially lower in low-income countries with younger populations. More...


Researchers at Imperial College London (Imperial; United Kingdom) screened 175 studies to update estimates of COVID-19 IFR. Based on 10 representative antibody surveys, they found that age-specific IFRs followed a log-linear pattern, with the risk of death doubling approximately every eight years of age. They estimated that overall IFR in a typical low-income country, with a population structure skewed towards younger individuals, was 0.23%. In contrast, in a typical high income country, with a greater concentration of elderly individuals, the overall IFR was 1.15%.

Age-specific IFRs increased from 0.1% for those under 40 years to greater than 5% among individuals over 80 years. When accounting for seroreversion—the waning of antibodies leading to a negative serological result-- the IFR was slightly reduced among surveys conducted several months after the first wave of the outbreak, such as in Italy. In contrast, uncertainty in test false positive rates, combined with low serological prevalence in some surveys, reconciled apparently low crude fatality ratios with the IFR in other countries. The findings were published on October 29, 2020, by the MRC Centre for Global Infectious Disease Analysis.

“Although the elderly are by far at the highest risk of dying due to COVID-19, the risk in middle age is still high. For example, we estimate that around one in 260 people aged 50-55 years die if infected,” said senior author Lucy Okell, PhD. “We calculated COVID-19 fatality largely based on the first wave of the epidemic in a number of countries, and we hope and expect to see some reduction in fatality now due to new clinical knowledge and treatment, but this remains a dangerous virus.”

“We know that antibody tests are not perfect, and there may be a considerable number of people who do not mount a detectable antibody response to SARS-CoV-2,” said study co-author Robert Verity, PhD. “However, even when this uncertainty is taken into account, we still find that COVID-19 has a high fatality rate, on the order of one percent for a typical high-income country. This risk is concentrated in older ages, with the probability of dying from COVID-19 doubling approximately every eight years.”

IFR is a key statistic for estimating disease burden, representing the proportion of deaths among all infected individuals. Previous estimates have relied on data early in the COVID-19 epidemic, or have not fully accounted for uncertainty in serological test characteristics and delays from onset of infection to seroconversion, death, and antibody waning.

Related Links:
Imperial College London


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Multi-Chamber Washer-Disinfector
WD 390
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Half-matched bone marrow transplant expands access to curative treatment for children and young adults with severe aplastic anemia. (Photo courtes of Margarita Dionysiou using Bio Render)

Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia

Severe aplastic anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells, leaving children and young adults vulnerable to anemia, infection, and bleeding.... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.